You are here

Home

Sturniolo Isotta

Sturniolo Isotta

Sturniolo Isotta
Name: Sturniolo Isotta

Publication list

printer-friendly version
Export to MTMT compatible RIS file
Upload publications
Request certified publication list
Uploaded publications:
5
Publications in DEA:
5
OA:
4
Date range:
2019-2024
2024
  1. Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
    Int. J. Mol. Sci. 25 (7), 1-21, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  2. Sturniolo, I., Váróczy, C., Bede, Á., Hegedűs, C., Demény, M., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
    J. Vis. Exp. 206 1-14, 2024.
    Journal metrics:
    Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    Q2 Chemical Engineering (miscellaneous) (2023)
    Q3 Immunology and Microbiology (miscellaneous) (2023)
    Q3 Neuroscience (miscellaneous) (2023)
2022
  1. Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
    Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.
    Journal metrics:
    Q1 Cancer Research
    Q1 Immunology
    Q1 Immunology and Allergy
    D1 Medicine (miscellaneous)
    Q1 Oncology
2020
2019
  1. Kumar, J., Murugaiah, V., Sotiriadis, G., Kaur, A., Jeyaneethi, J., Sturniolo, I., Alhamlan, F., Chatterjee, J., Hall, M., Kishore, U., Karteris, E.: Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
    Front Oncol. 9 1-14, 2019.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
updated: 2024-12-15, 01:42

SCImago quartiles of
scientific journal articles

Number of scientific articles: 5
Q1/D1 2 (40%)
Q1 4 (80%)
Q2 1 (20%)
-
OK

SCImago subject areas and categories

Biochemistry, Genetics and Molecular Biology (5)
Cancer Research (3)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (1)
Molecular Biology (1)
Medicine (4)
Oncology (3)
Medicine (miscellaneous) (2)
Immunology and Allergy (1)
Chemical Engineering (2)
Catalysis (1)
Chemical Engineering (miscellaneous) (1)
Immunology and Microbiology (2)
Immunology (1)
Immunology and Microbiology (miscellaneous) (1)
Chemistry (1)
Inorganic Chemistry (1)
Organic Chemistry (1)
Physical and Theoretical Chemistry (1)
Spectroscopy (1)
Computer Science (1)
Computer Science Applications (1)
Neuroscience (1)
Neuroscience (miscellaneous) (1)

Genre chart

Year chart

Language chart